189 related articles for article (PubMed ID: 23396492)
1. Statin treatment and the risk of recurrent pulmonary embolism.
Biere-Rafi S; Hutten BA; Squizzato A; Ageno W; Souverein PC; de Boer A; Gerdes VE; Büller HR; Kamphuisen PW
Eur Heart J; 2013 Jun; 34(24):1800-6. PubMed ID: 23396492
[TBL] [Abstract][Full Text] [Related]
2. Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease.
Sicras-Mainar A; Planas-Comes A; Frias-Garrido X; Navarro-Artieda R; de Salas-Cansado M; Rejas-Gutiérrez J
J Clin Pharm Ther; 2012 Aug; 37(4):441-7. PubMed ID: 22059532
[TBL] [Abstract][Full Text] [Related]
3. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
4. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
5. Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism.
White RH; Zhou H; Murin S
Thromb Haemost; 2008 Apr; 99(4):683-90. PubMed ID: 18392326
[TBL] [Abstract][Full Text] [Related]
6. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
8. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.
van Dongen CJ; Vink R; Hutten BA; Büller HR; Prins MH
Arch Intern Med; 2003 Jun; 163(11):1285-93. PubMed ID: 12796064
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.
den Exter PL; Hooijer J; Dekkers OM; Huisman MV
J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
Tagalakis V; Patenaude V; Kahn SR; Suissa S
Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
[TBL] [Abstract][Full Text] [Related]
11. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
12. Acute pulmonary embolism during warfarin therapy and long-term risk of recurrent fatal pulmonary embolism.
Moutzouris JP; Ng AC; Chow V; Chung T; Curnow J; Kritharides L
Thromb Haemost; 2013 Sep; 110(3):523-33. PubMed ID: 23740364
[TBL] [Abstract][Full Text] [Related]
13. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
Tagalakis V; Eberg M; Kahn S; Azoulay L
Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
[TBL] [Abstract][Full Text] [Related]
14. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival.
Milionis HJ; Giannopoulos S; Kosmidou M; Panoulas V; Manios E; Kyritsis AP; Elisaf MS; Vemmos K
Neurology; 2009 May; 72(21):1816-22. PubMed ID: 19470963
[TBL] [Abstract][Full Text] [Related]
16. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
17. Dose-related effect of statins in venous thrombosis risk reduction.
Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
[TBL] [Abstract][Full Text] [Related]
18. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of patients after venous thromboembolism.
Kearon C
Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
[TBL] [Abstract][Full Text] [Related]
20. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
